Skip to main content
Clinical Trials/CTRI/2014/03/004446
CTRI/2014/03/004446
Recruiting
未知

Tumor specific whole genome expression analysis to determine patient specific chemotherapies and/or adjuvant therapies

Mazumdar Shaw Medical Center0 sites14 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Newly Diagnosed or recurrent Leukemia
Sponsor
Mazumdar Shaw Medical Center
Enrollment
14
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Mazumdar Shaw Medical Center

Eligibility Criteria

Inclusion Criteria

  • Newly Diagnosed and recurrent Leukemia
  • \- Willing to provide informed consent

Exclusion Criteria

  • \-Patients with the history of heart diseases. e.g., NYHA Functional Class III or IV heart failure, Myocardial Infarction within 6 months , ventricular tachyarrhythmias requiringongoing treatment, or unstable angina, or heart rhythm disorder
  • \-Patients with the history of psychological problems that would precludeparticipation in the study(like confusion, hallucination, loss of balance, change in the way you walk or talk, decreased).
  • \-Patients for whom, in the opinion of the investigator, their general status would not permit the administration of chemotherapy
  • \-Inability of the patient or Legally Acceptable Representative to give the informed consent.
  • \-Patients who are participating in another clinical trial currently.

Outcomes

Primary Outcomes

Not specified

Similar Trials